Fake weight-loss tablets are set to flood Britain, experts warn, as the pharmaceutical industry launches tablet forms of popular injectable medications. The move could lead to a surge in counterfeit pills, which could be easier for scammers to produce and distribute due to lower production costs.
The demand for weight-loss treatments has grown significantly in recent years, with trials showing that certain injections can help people lose up to 20% of their body weight. However, the jabs are expensive, require an injection pen and needles, and must be refrigerated, making them less accessible to some.
Now, pharmaceutical companies are working on oral versions of these medications, creating tablets containing drugs that mimic the hormone GLP-1. While this could improve access for some people, experts warn that it also increases the opportunity for scammers to falsify the pills.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has repeatedly warned consumers about the dangers of counterfeit weight-loss medications, which can include medications taken out of the legitimate supply chain or contaminated with incorrect active ingredients. Dr Bernard Naughton, an associate professor at Trinity College Dublin, says that even when people think there may be something wrong with a medication, they are often still willing to take the risk and buy it online.
The MHRA has been taking action against counterfeiters, but experts warn that stronger regulation and enforcement are needed to prevent this type of fraud. Novo Nordisk, the manufacturer of the pill form of Wegovy, says that its product is subject to rigorous regulatory processes and ongoing oversight, while Eli Lilly also takes steps to combat counterfeits.
The UK needs to do more to protect consumers from fake weight-loss medications, according to experts. Oksana Pyzik, an associate professor at UCL school of pharmacy, says that patients need to know that they should only access these products with a prescription and under medical supervision.
In addition to stronger regulation, the UK also needs to develop public health campaigns targeting groups with different motivations and attitudes to risk when it comes to buying medications online. Dr Naughton says that this is crucial because there is value in buying medicines online, and it provides access to people who wouldn't have access otherwise.
The demand for weight-loss treatments has grown significantly in recent years, with trials showing that certain injections can help people lose up to 20% of their body weight. However, the jabs are expensive, require an injection pen and needles, and must be refrigerated, making them less accessible to some.
Now, pharmaceutical companies are working on oral versions of these medications, creating tablets containing drugs that mimic the hormone GLP-1. While this could improve access for some people, experts warn that it also increases the opportunity for scammers to falsify the pills.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has repeatedly warned consumers about the dangers of counterfeit weight-loss medications, which can include medications taken out of the legitimate supply chain or contaminated with incorrect active ingredients. Dr Bernard Naughton, an associate professor at Trinity College Dublin, says that even when people think there may be something wrong with a medication, they are often still willing to take the risk and buy it online.
The MHRA has been taking action against counterfeiters, but experts warn that stronger regulation and enforcement are needed to prevent this type of fraud. Novo Nordisk, the manufacturer of the pill form of Wegovy, says that its product is subject to rigorous regulatory processes and ongoing oversight, while Eli Lilly also takes steps to combat counterfeits.
The UK needs to do more to protect consumers from fake weight-loss medications, according to experts. Oksana Pyzik, an associate professor at UCL school of pharmacy, says that patients need to know that they should only access these products with a prescription and under medical supervision.
In addition to stronger regulation, the UK also needs to develop public health campaigns targeting groups with different motivations and attitudes to risk when it comes to buying medications online. Dr Naughton says that this is crucial because there is value in buying medicines online, and it provides access to people who wouldn't have access otherwise.